Elaina N. Haeuber, M.S.

Elaina Haeuber brings more than 20 years of clinical research operations and project management experience in biotech and CRO settings. She has overseen a portfolio of oncology initiatives at the executive level, covering all study phases across multiple indications, cell and gene therapy, and immuno- and targeted treatments. Programs she supported led to marketing approval in both the US and EMA.

Haeuber’s prior biopharmaceutical industry experience includes leadership roles at Actinium Pharmaceuticals, Syneos Health, WCG, and PPD. She earned a B.A. from Boston University and an M.S. from the University of Illinois at Chicago.